Inhibitory effect and related mechanism of decitabine combined with gemcitabine on proliferation of NK/T cell lymphoma cells

Background: EBV-associated lymphoma is a neoplasm with a poor prognosis, highly aggressive, and progressive rapidly. There is no standard clinical treatment protocol. Decitabine and gemcitabine are known to have anticancer properties against cells of various cancer, respectively. However, the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lanke, Liu, Xiangqin, Yu, Hui, Deng, Huan, Peng, Kun, Chen, Jiang, Zhang, Chunle, Jiang, Tao, Liu, Xiaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014839/
https://www.ncbi.nlm.nih.gov/pubmed/36937854
http://dx.doi.org/10.3389/fphar.2023.1134895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014839/
https://www.ncbi.nlm.nih.gov/pubmed/36937854
http://dx.doi.org/10.3389/fphar.2023.1134895

Ejemplares similares